BRIACELL THERAPEUTICS CORP - COM NEW (BCTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2020 to Q2 2024

Type / Class
Equity / COM NEW
Symbol
BCTX on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of BRIACELL THERAPEUTICS CORP - COM NEW (BCTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q2 0 $0 -$34 0
2024 Q1 12 $34 -$1,755 $2.83 1
2023 Q4 312 $1,825 -$9,888,557 $5.84 2
2023 Q3 1,582,462 $9,890,387 -$7,674,319 $6.25 2
2023 Q2 2,777,510 $17,833,968 +$1,133,051 $6.42 20
2023 Q1 2,602,680 $19,384,102 -$244,749 $7.45 21
2022 Q4 2,663,812 $12,301,333 +$735,626 $4.37 19
2022 Q3 2,533,454 $14,293,000 -$2,552,773 $5.62 18
2022 Q2 2,967,631 $17,045,000 -$4,431,283 $5.77 19
2022 Q1 3,302,277 $33,528,070 +$20,302,849 $10.14 16
2021 Q4 1,317,463 $10,909,140 -$686,993 $8.28 17
2021 Q3 589,756 $4,772,000 -$16,171,988 $8.10 19
2021 Q2 3,801,628 $20,265,000 +$17,029,576 $5.33 22
2021 Q1 375,017 $1,446,000 +$1,446,000 $3.86 7
2020 Q4 0 $0 -$3,000 0
2020 Q3 774 $3,000 $3.88 1
2020 Q2 774 $4,000 +$4,000 $5.17 1